共 50 条
- [1] Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE studyJOURNAL OF CROHNS & COLITIS, 2020, 14 : S580 - S581D'Haens, G.Hebuterne, X.Higgins, P. D. R.Loftus, E. V., Jr.Zhou, W.Lacerda, A. P.Xie, W.Liu, J.Danese, S.
- [2] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313Danese, SilvioVermeire, SeverineZhou, WenPangan, AileenSiffledeen, JesseHebuterne, XavierNakase, HiroshiChen, MinhuHiggins, PeterSanchez-Gonzalez, YuriHuang, BidanXian, WangangLiu, JianzhongWeinreich, MichaelPanaccione, Remo
- [3] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE studyJOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024Danese, S.Vermeire, S.Zhou, W.Pangan, A.Siffledeen, J.Hebuterne, X.Nakase, H.Higgins, P.Chen, M. H.Sanchez-Gonzalez, Y.Huang, B.Xie, W.Liu, J.Weinreich, M.Pannaccione, R.
- [4] THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTSGASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1103D'Haens, GeertTran, Jacinda N.Danese, SilvioRubin, David T.Aoyama, NobuoLugering, AndreasKlaff, JustinXuan, SiIlo, DapoGonzalez, Yuri SanchezPanes, Julian
- [5] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522Vermeire, SeverineDanese, SilvioZhou, WenYao, XuanIlo, DapoLiu, JohnHebuterne, XavierLindsay, JamesSanchez-Gonzalez, YuriHiggins, Peter D.Colombel, Jean-FredericPanaccione, Remo
- [6] Effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH resultsJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 137 - 138Pudipeddi, A.D'Haens, G.Tran, J.Danese, S.Rubin, D. T.Aoyama, N.Luegering, A.Klaff, J.Xuan, S.Ilo, D.Gonzalez, Y. SanchezPanes, J.
- [7] The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH resultsJOURNAL OF CROHNS & COLITIS, 2023, 17 : I27 - I29D'Haens, G.Tran, J.Danese, S.Rubin, D. T.Aoyama, N.Lugering, A.Klaff, J.Xuan, S.Ilo, D.Gonzalez, Y. SanchezPanes, J.
- [8] Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE studyJOURNAL OF CROHNS & COLITIS, 2019, 13 : S9 - S9Sandborn, W. J.Schreiber, S.Lee, S. D.Lindsay, J. O.Hebuterne, X.Zhou, W.Cataldi, F.Lacerda, A. P.Huang, B.Xie, W.Loftus, E. V., Jr.
- [9] Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately-to-Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U-ACHIEVEAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S131 - S131Higgins, PeterHebuterne, XavierSiffledeen, JesseZhou, WenCataldi, FabioXie, WangangLacerda, AnaDanese, Silvio
- [10] IMPROVED ENDOSCOPIC OUTCOMES AND MUCOSAL HEALING OF UPADACITINIB AS AN INDUCTION THERAPY IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE U-ACHIEVE STUDYGASTROENTEROLOGY, 2019, 156 (06) : S170 - S171Sandborn, William J.Schreiber, StefanLee, Scott D.Lindsay, James O.Hebuterne, XavierZhou, WenCataldi, FabioLacerda, Ana P.Huang, BidanXie, WangangLoftus, Edward V.